Aim: In recent years, we have seen a considerable increase in the relevance of nanostructures for the safe delivery of therapeutic agents and their capacity as an immunomodulatory tool.
Materials and methods: Potential clinical applications related to their unique structural properties have been described in the evolving landscape of immunotherapy.
Results: This review briefly summarizes the evidence for the role of nanoparticles in regulating the immune response.
Conclusions: Their main features to highlight how to provide an innovative means of biomedical application to oncology research.
Keywords: Carbon nanocarriers; Dendrimers; Gold nanoparticles; Homing; Liposomes; Nanotechnology.